Publication Cover
New Genetics and Society
Critical Studies of Contemporary Biosciences
Volume 41, 2022 - Issue 2
1,768
Views
1
CrossRef citations to date
0
Altmetric
Articles

Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns

ORCID Icon & ORCID Icon
Pages 96-115 | Received 30 Sep 2021, Accepted 30 May 2022, Published online: 26 Jun 2022

References

  • ACHDNC (Advisory Committee on Heritable Disorders in Newborns and Children). 2020. Recommended Uniform Screening Panel. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp/index.html.
  • Adhikari, Aashish, Renata Gallagher, Yaqiong Wang, Robert Currier, George Amatuni, Laia Bassaganyas, Flavia Chen, et al. 2020. “The Role of Exome Sequencing in Newborn Screening for Inborn Errors of Metabolism.” Nature Medicine 26: 1392–1397.
  • Ballard, Lisa, Rachel Horton, Angela Fenwick, and Anneke Lucassen. 2020. “Genome Sequencing in Healthcare: Understanding the UK General Public’s Views and Implications for Clinical Practice.” European Journal of Human Genetics 28 (2): 155–164.
  • Barajas, Miguel, and Lainie Ross. 2015. “Pediatric Professionals’ Attitudes About Secondary Findings in Genomic Sequencing of Children.” Journal of Pediatrics 166 (5): 1276–U516.
  • Biesecker, Leslie, Eric Green, Teri Manolio, Benjamin Solomon, and David Curtis. 2021. “Should all Babies Have Their Genome Sequenced at Birth?” BMJ 375: 2679.
  • Blom, Maartje, Michiel Schoenaker, Myrthe Hulst, Martine de Vries, Corry Weemaes, Michèl Willemsen, Lidewij Henneman, and Mirjam van der Burg. 2019. “Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia.” Frontiers in Immunology 10: 2438–2438.
  • Bollinger, Juli, Joan Scott, Rachel Dvoskin, and David Kaufman. 2012. “Public Preferences Regarding the Return of Individual Genetic Research Results: Findings from a Qualitative Focus Group Study.” Genetics in Medicine 14 (4): 451–457.
  • Bombard, Yvonne, Fiona Miller, Robin Hayeems, Carolyn Barg, Celine Cressman, June Carroll, Brenda Wilson, et al. 2014. “Public Views on Participating in Newborn Screening Using Genome Sequencing.” European Journal of Human Genetics 22 (11): 1248–1254.
  • Botkin, Jeffrey. 2009. “Assessing the New Criteria for Newborn Screening.” Health Matrix 19: 163–186.
  • Briscoe, Forrest, Ifeoma Ajunwa, Allison Gaddis, and Jennifer McCormick. 2020. “Evolving Public Views on the Value of One’s DNA and Expectations for Genomic Database Governance: Results from a National Survey.” PLoS One 15 (3): e0229044.
  • Brittain, Helen, Richard Scott, and Ellen Thomas. 2017. “The Rise of the Genome and Personalised Medicine.” Clinical Medicine (London, England) 17 (6): 545–551.
  • Cacchione, Pauline. 2016. “The Evolving Methodology of Scoping Reviews.” Clincal Nursing Research 25 (2): 115–119.
  • Campbell, Elizabeth, and Lainie Ross. 2005. “Parental Attitudes and Beliefs Regarding the Genetic Testing of Children.” Community Genetics 8 (2): 94–102.
  • Canedo, Juan, Stephania Miller, Hector Myers, and Maureen Sanderson. 2019. “Racial and Ethnic Differences in Knowledge and Attitudes About Genetic Testing in the US: Systematic Review.” Journal of Genetic Counseling 28 (3): 587–601.
  • Daack-Hirsch, Sandra, Martha Driessnack, Alyson Hanish, Vanessa Johnson, Lisa Shah, Christian Simon, and Janet Williams. 2013. “Information is Information: A Public Perspective on Incidental Findings in Clinical and Research Genome-Based Testing.” Clinical Genetics 84 (1): 11–18.
  • DeLuca, Jane. 2018. “Public Attitudes Toward Expanded Newborn Screening.” Journal of Pediatric Nursing 38: e19–e23.
  • Detmar, Symone, Nynke Dijkstra, Niels Nijsingh, Marlies Rijnders, Marcel Verweij, and Esther Hosli. 2008. “Parental Opinions About the Expansion of the Neonatal Screening Programme.” Public Health Genomics 11 (1): 11–17.
  • DHSC (Department of Health and Social Care). 2020. Genome UK: The Future of Healthcare. https://www.gov.uk/government/publications/genome-uk-the-future-of-healthcare.
  • Dodson, Daniel, Aaron Goldenberg, Matthew Davis, Dianne Singer, and Beth Tarini. 2015. “Parent and Public Interest in Whole-Genome Sequencing.” Public Health Genomics 18 (3): 151–159.
  • Downie, Lilian, Jane Halliday, Sharon Lewis, and David Amor. 2021. “Principles of Genomic Newborn Screening Programs: A Systematic Review.” JAMA Network Open 4 (7): e2114336.
  • Etchegary, Holly, Brenda Wilson, Proton Rahman, Charlene Simmonds, and Daryl Pullman. 2020. “Public Interest in Whole Genome Sequencing and Information Needs: An Online Survey Study.” Personalized Medicine 17 (4): 283–293.
  • Etchegary, Holly, Mercy Winsor, Angela Power, and Charlene Simmonds. 2021. “Public Engagement with Genomic Medicine: A Summary of Town Hall Discussions.” Journal of Community Genetics 12 (1): 27–35.
  • Fernandez, Conrad, Eric Bouffet, David Malkin, Nada Jabado, Colleen O'Connell, Denise Avard, Bartha Knoppers, et al. 2014. “Attitudes of Parents Toward the Return of Targeted and Incidental Genomic Research Findings in Children.” Genetics in Medicine 16 (8): 633–640.
  • Genetic-Alliance-UK. 2019. Fixing the Present Building for the Future: Newborn Screening for Rare Conditions. London: Genetic Alliance UK. https://geneticalliance.org.uk/wp-content/uploads/2020/01/Newborn-Screening-Report.pdf.
  • Gigerenzer, Gerd. 2015. “Towards a Paradigm Shift in Cancer Screening: Informed Citizens Instead of Greater Participation.” BMJ: British Medical Journal 350: h2175.
  • Goldenberg, Aaron, Daniel Dodson, Matthew Davis, and Beth Tarini. 2014. “Parents’ Interest in Whole-Genome Sequencing of Newborns.” Genetics in Medicine 16 (1): 78–84.
  • Grob, Rachel. 2008. “Is my Sick Child Healthy? Is my Healthy Child Sick? Changing Parental Experiences of Cystic Fibrosis in the Age of Expanded Newborn Screening.” Social Science & Medicine 67 (7): 1056–1064.
  • Groisman, Iris, Thierry Hurlimann, and Béatrice Godard. 2019. “Parents of a Child with Epilepsy: Views and Expectations on Receiving Genetic Results from Whole Genome Sequencing.” Epilepsy & Behavior 90: 178–190.
  • Haga, Susanne, Willian Barry, Rachel Mills, Geoffrey Ginsburg, Laura Svetkey, Jennifer Sullivan, and Huntington Willard. 2013. “Public Knowledge of and Attitudes Toward Genetics and Genetic Testing.” Genetic Testing and Molecular Biomarkers 17 (4): 327–335.
  • Harris, Erin, Sonja Ziniel, Jonathan Amatruda, Catherine Clinton, Sarah Savage, Patrick Taylor, Noelle Huntington, Robert Green, and Ingrid Holm. 2012. “The Beliefs, Motivations, and Expectations of Parents Who Have Enrolled Their Children in a Genetic Biorepository.” Genetics in Medicine 14 (3): 330–337.
  • Hasegawa, Lianne, Kathleen Fergus, N. Ojeda, and Sylvia Au. 2011. “Parental Attitudes Toward Ethical and Social Issues Surrounding the Expansion of Newborn Screening Using New Technologies.” Public Health Genomics 14 (4-5): 298–306.
  • Hassan, Lamiece, Ann Dalton, Carrie Hammond, and Mary Tully. 2020. “A Deliberative Study of Public Attitudes Towards Sharing Genomic Data Within NHS Genomic Medicine Services in England.” Public Understanding of Science 29 (7): 702–717.
  • Hiraki, Susan, Kelly Ormond, Katherine Kim, and Lainie Ross. 2006. “Attitudes of Genetic Counselors Towards Expanding Newborn Screening and Offering Predictive Genetic Testing to Children.” American Journal of Medical Genetics Part A 140A (21): 2312–2319.
  • Hoffmann, Tammy, and Chris Del Mar. 2015. “Patients’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review.” JAMA Internal Medicine 175 (2): 274–286.
  • Hopkins Van Mil. 2020. Implications for Whole Genome Sequencing (WGS) for Newborn Screening Public Dialogue: A Findings Report. https://www.genomicsengland.co.uk/public-dialogue-genomics-newborn-screening.
  • Iskrov, Georgi, Stefan Ivanov, Stephen Wrenn, and Rumen Stefanov. 2017. “Whole-Genome Sequencing in Newborn Screening-Attitudes and Opinions of Bulgarian Pediatricians and Geneticists.” Frontiers in Public Health 5: 308–308.
  • JCGM (Joint Committee of Genomics in Medicine). 2019. Consent and Confidentiality in Genomic Medicine: 3rd Edition. https://www.bsgm.org.uk/healthcare-professionals/confidentiality-and-genetic-information/.
  • Joseph, Galen, Flavia Chen, Julie Harris-Wai, Jennifer Puck, Charlotte Young, and Barbara Koenig. 2016. “Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.” Pediatrics 137 (Suppl. 1): S36–S46.
  • Kerruish, Nicola. 2016. “Parents’ Experiences 12 Years After Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Their Attitudes to Whole-Genome Sequencing in Newborns.” Genetics in Medicine 18 (3): 249–258.
  • Leppert, Kristen, Katharine Bisordi, Jessica Nieto, Kristin Maloney, Yue Guan, Shannan Dixon, and Alena Egense. 2018. “Genetic Counselors’ Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.” Journal of Genetic Counseling 27: 1–13.
  • Levenseller, Brooke, Danielle Soucier, Victoria Miller, Diana Harris, Laura Conway, and Barbara Bernhardt. 2014. “Stakeholders’ Opinions on the Implementation of Pediatric Whole Exome Sequencing: Implications for Informed Consent.” Journal of Genetic Counseling 23 (4): 552–565.
  • Loeber, Gerard, Dimitris Platis, Rolf Zetterström, Shlomo Almashanu, François Boemer, James Bonham, Patricia Borde, et al. 2021. “Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010.” International Journal of Neonatal Screening 7 (1): 15.
  • Lohn, Zoe, Shelin Adam, Patricia Birch, Anne Townsend, and Jan Friedman. 2013. “Genetics Professionals’ Perspectives on Reporting Incidental Findings from Clinical Genome-Wide Sequencing.” American Journal of Medical Genetics Part A 161 (3): 542–549.
  • Lucassen, Anneke, and Roy Gilbar. 2018. “Alerting Relatives About Heritable Risks: The Limits of Confidentiality.” BMJ 361: k1409.
  • Mackley, Michael, Edward Blair, Michael Parker, Jenny Taylor, Hugh Watkins, and Elizabeth Ormondroyd. 2018. “Views of Rare Disease Participants in a UK Whole-Genome Sequencing Study Towards Secondary Findings: A Qualitative Study.” European Journal of Human Genetics 26 (5): 652–659.
  • Mackley, Michael, Benjamin Fletcher, Michael Parker, Hugh Watkins, and Elizabeth Ormondroyd. 2017. “Stakeholder Views on Secondary Findings in Whole-Genome and Whole-Exome Sequencing: A Systematic Review of Quantitative and Qualitative Studies.” Genetics in Medicine 19 (3): 283–293.
  • Markens, Susan, Carole Browner, and Mabel Preloran. 2010. “Interrogating the Dynamics Between Power, Knowledge and Pregnant Bodies in Amniocentesis Decision Making.” Sociology of Health & Illness 32 (1): 37–56.
  • McCullough, Laurence, Melody Slashinski, Amy McGuire, Richard Street, Christine Eng, Richard Gibbs, William Parsons, and Sharon Plon. 2016. “Is Whole-Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients with Solid Tumors.” Pediatric Blood & Cancer 63 (3): 511–515.
  • McGuire, Amy, Christina Diaz, Tao Wang, and Susan Hilsenbeck. 2009. “Social Networkers’ Attitudes Toward Direct-to-Consumer Personal Genome Testing.” American Journal of Bioethics 9 (6-7): 3–10.
  • Middleton, Anna, Richard Milne, Heidi Howard, Emilia Niemiec, Lauren Robarts, Christine Critchley, Dianne Nicol, et al. 2020. “Members of the Public in the USA, UK, Canada and Australia Expressing Genetic Exceptionalism say They are More Willing to Donate Genomic Data.” European Journal of Human Genetics 28 (4): 424–434.
  • Middleton, Anna, Katherine Morley, Eugene Bragin, Helen Firth, Matthew Hurles, Caroline Wright, and Michael Parker. 2016. “Attitudes of Nearly 7000 Health Professionals, Genomic Researchers and Publics Toward the Return of Incidental Results from Sequencing Research.” European Journal of Human Genetetics 24 (1): 21–29.
  • Mighton, Chloe, Salma Shickh, Elizabeth Uleryk, Petros Pechlivanoglou, and Yvonne Bombard. 2020. “Clinical and Psychological Outcomes of Receiving a Variant of Uncertain Significance from Multigene Panel Testing or Genomic Sequencing: A Systematic Review and Meta-Analysis.” Genetics in Medicine 23: 22–33.
  • Miller, Fiona, Robin Hayeems, Yvonne Bombard, Céline Cressman, Carolyn Barg, June Carroll, Brenda Wilson, et al. 2015. “Public Perceptions of the Benefits and Risks of Newborn Screening.” Pediatrics 136 (2): e413–e423.
  • Miller, Fiona, Robin Hayeems, Yvonne Bombard, Julian Little, June Carroll, Brenda Wilson, Judith Allanson, et al. 2009. “Clinical Obligations and Public Health Programmes: Healthcare Provider Reasoning About Managing the Incidental Results of Newborn Screening.” Journal of Medical Ethics 35 (10): 626–634.
  • Moultrie, Rebecca, Ryan Paquin, Christine Rini, Myra Roche, Jonathan Berg, Cynthia Powell, and Megan Lewis. 2020. “Parental Views on Newborn Next Generation Sequencing: Implications for Decision Support.” Maternal and Child Health Journal 24 (7): 856–864.
  • Nardini, Monica, Anne Matthews, Shawn McCandless, Larisa Baumanis, and Aaron Goldenberg. 2014. “Genomic Counseling in the Newborn Period: Experiences and Views of Genetic Counselors.” Journal of Genetic Counseling 23 (4): 506–515.
  • Newborn Genomes Programme. 2022. Vision. https://s3.eu-west-2.amazonaws.com/ge-production-s3/documents/Newborns-Vision-Final_SEP_2021-11-02-122418_jjne.pdf.
  • Nicholls, Stuart. 2012. “Proceduralisation, Choice and Parental Reflections on Decisions to Accept Newborn Bloodspot Screening.” Journal of Medical Ethics 38 (5): 299–303.
  • Nicholls, Stuart, Brenda Wilson, Samantha Craigie, Holly Etchegary, David Castle, June Carroll, Beth Potter, Louise Lemyre, and Julian Little. 2013. “Public Attitudes Towards Genomic Risk Profiling as a Component of Routine Population Screening.” Genome 56 (10): 626–633.
  • Øyen, Liv, and Ingvild Aune. 2016. “Viewing the Unborn Child – Pregnant Women’s Expectations, Attitudes and Experiences Regarding Fetal Ultrasound Examination.” Sexual & Reproductive Healthcare 7: 8–13.
  • Paul, Elise, Andrew Steptoe, and Daisy Fancourt. 2021. “Attitudes Towards Vaccines and Intention to Vaccinate Against COVID-19: Implications for Public Health Communications.” The Lancet Regional Health – Europe 1: 100012.
  • Pereira, Stacey, Jill Robinson, Amanda Gutierrez, Devan Petersen, Rebecca Hsu, Caroline Lee, Talia Schwartz, et al. 2019. Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project.” Pediatrics 143 (Suppl. 1): S6–S13.
  • Peters, Micah, Christina Godfrey, Hanan Khalil, Patricia McInerney, Deborah Parker, and Cassia Soares. 2015. “Guidance for Conducting Systematic Scoping Reviews.” JBI Evidence Implementation 13 (3): 141–146.
  • PHE (Public Health England). 2018. Newborn Blood Spot Screening Programme in the UK. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/709367/Newborn_blood_spot_screening_data_collection_and_performance_analysis_report_2016_to_2017.pdf.
  • Pitt, James. 2010. “Newborn Screening.” The Clinical Biochemist. Reviews 31 (2): 57–68.
  • Quinlivan, Julie, and Christine Suriadi. 2006. “Attitudes of New Mothers Towards Genetics and Newborn Screening.” Journal of Psychosomatic Obstetrics & Gynecology 27 (1): 67–72.
  • Ryan, Kerry, Raymond De Vries, Wendy Uhlmann, J. Scott Roberts, and Michele Gornick. 2017. “Public’s Views Toward Return of Secondary Results in Genomic Sequencing: It’s (Almost) All About the Choice.” Journal of Genetic Counseling 26 (6): 1197–1212.
  • Sapp, Julie, Danielle Dong, Caryn Stark, Lauren Ivey, Gillian Hooker, Leslie Biesecker, and Barbara Biesecker. 2014. “Parental Attitudes, Values, and Beliefs Toward the Return of Results from Exome Sequencing in Children.” Clinical Genetics 85 (2): 120–126.
  • Saunders, Carol, Neil Miller, Sarah Soden, Darrell Dinwiddie, Aaron Noll, Noor Abu-Alnadi, Nevene Andraws, et al. 2012. “Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units.” Science Translational Medicine 4: 154.
  • Shabani, Mahsa, Louise Bezuidenhout, and Pascal Borry. 2014. “Attitudes of Research Participants and the General Public Towards Genomic Data Sharing: A Systematic Literature Review.” Expert Review of Molecular Diagnostics 14 (8): 1053–1065.
  • Starr, Sandy. 2015. “What You Think About the Benefits and Risks of Whole Genome Sequencing.” BioNews 804. https://www.bionews.org.uk/page_94998.
  • Timmermans, Stefan, and Mara Buchbinder. 2010. “Patients-in-waiting: Living Between Sickness and Health in the Genomics RA.” Journal of Health and Social Behavior 51 (4): 408–423.
  • Tolusso, Leandra, Kathleen Collins, Xue Zhang, Jennifer Holle, Alexander Valencia, and Melanie Myers. 2017. “Pediatric Whole Exome Sequencing: An Assessment of Parents’ Perceived and Actual Understanding.” Journal of Genetic Counseling 26 (4): 792–805.
  • Townsend, Anne, Shelin Adam, Patricia Birch, Zoe Lohn, Francois Rousseau, and Jan Friedman. 2012. “I Want to Know What’s in Pandora’s Box: Comparing Stakeholder Perspectives on Incidental Findings in Clinical Whole Genomic Sequencing.” American Journal of Medical Genetics A 158a (10): 2519–2525.
  • Ulm, Elizabeth, William Feero, Richard Dineen, Joel Charrow, and Catherine Wicklund. 2015. “Genetics Professionals’ Opinions of Whole-Genome Sequencing in the Newborn Period.” Journal of Genetic Counseling 24 (3): 452–463.
  • Ulph, Fiona, Tim Cullinan, Nadeem Qureshi, and Joe Kai. 2014. “Informing Children of Their Newborn Screening Carrier Result for Sickle Cell or Cystic Fibrosis: Qualitative Study of Parents’ Intentions, Views and Support Needs.” Journal of Genetic Counselling 23 (3): 409–420.
  • Ulph, Fiona, Nimarta Dharni, Rebecca Bennett, and Tina Lavender. 2020. “Consent for Newborn Screening: Screening Professionals’ and Parents’ Views.” Public Health 178: 151–158.
  • Waisbren, Susan, Danielle Bäck, Christina Liu, Sarah Kalia, Steven Ringer, Ingrid Holm, and Robert Green. 2015. “Parents are Interested in Newborn Genomic Testing During the Early Postpartum Period.” Genetics in Medicine 17 (6): 501–504.
  • Yu, Joon-Ho, Tanya Harrell, Seema Jamal, Holly Tabor, and Michael Bamshad. 2014. “Attitudes of Genetics Professionals Toward the Return of Incidental Results from Exome and Whole-Genome Sequencing.” American Journal of Human Genetics 95 (1): 77–84.